Immune Responses after a Third Dose of mRNA Vaccine Differ in Virus-Naive versus SARS-CoV-2– Recovered Dialysis Patients | Zendy

Philippe Attias | Zendy; Imane Azzaoui | Zendy; Khalil El Karoui | Zendy; A. SELLE | Zendy; Aurélien Sokal | Zendy; Pascal Chappert | Zendy; Philippe Grimbert | Zendy; I. Fernández | Zendy; Magali BouvierAlias | Zendy; Chloé Samson | Zendy; Djamal Dahmane | Zendy; Philippe Rieu | Zendy; Patrice Nizard | Zendy; Slim Fourati | Zendy; Hamza Sakhi | Zendy; Matthieu Mahévas | Zendy

Open Access

Immune Responses after a Third Dose of mRNA Vaccine Differ in Virus-Naive versus SARS-CoV-2– Recovered Dialysis Patients

Author(s) -

Philippe Attias,

Imane Azzaoui,

Khalil El Karoui,

A. SELLE,

Aurélien Sokal,

Pascal Chappert,

Philippe Grimbert,

I. Fernández,

Magali BouvierAlias,

Chloé Samson,

Djamal Dahmane,

Philippe Rieu,

Patrice Nizard,

Slim Fourati,

Hamza Sakhi,

Matthieu Mahévas

Publication year - 2022

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.00830122

Subject(s) - medicine , immune system , dialysis , covid-19 , virology , virus , sars virus , immunology , outbreak , disease , infectious disease (medical specialty)

After two doses of mRNA vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), patients on dialysis show a defective humoral response, but a third dose could increase anti-SARS-CoV-2 spike IgG titers. Responses could be different in virus-naive and SARS-CoV-2-recovered patients on dialysis. However, characterization of memory B cell response after three doses is lacking.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research